A nurse is teaching a client who is starting subcutaneous leuprolide for the treatment of prostate cancer. Which of the following information should the nurse include in the teaching?
Increase calcium intake.
Keep the solution cold for administration.
This medication can cause low blood glucose levels.
This medication can cause constipation.
The Correct Answer is A
Rationale:
A. Increase calcium intake: Leuprolide can cause a decrease in bone density, increasing the risk of osteoporosis. Therefore, the nurse should advise the client to increase calcium and vitamin D intake to help maintain bone health.
B. Keep the solution cold for administration: Leuprolide should be stored at room temperature, not refrigerated, for subcutaneous administration.
C. This medication can cause low blood glucose levels: Leuprolide does not typically affect blood glucose levels. However, it can cause other endocrine-related side effects, such as hot flashes and reduced libido.
D. This medication can cause constipation: Constipation is not a common side effect of leuprolide. Instead, leuprolide is more likely to cause side effects such as hot flashes and loss of bone density.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
Rationale:
A. Sargramostim is a granulocyte-macrophage colony-stimulating factor (GM-CSF) used to stimulate the production of white blood cells but is not specifically indicated for anemia.
B. Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that increases white blood cell counts and is not used for treating anemia.
C. Epoetin is an erythropoiesis-stimulating agent that stimulates red blood cell production, making it the appropriate choice for treating chemotherapy-induced anemia.
D. Romiplostim is a thrombopoietin receptor agonist used to treat thrombocytopenia (low platelet count) and is not indicated for anemia.
Correct Answer is A
Explanation
Rationale:
A. Frequent sputum tests may be needed to monitor the effectiveness of isoniazid, particularly in assessing the resolution of tuberculosis infection.
B. Isoniazid is usually prescribed for a minimum of six months for tuberculosis treatment, not just a month. Thus, stopping after one month is incorrect.
C. Antacids containing aluminum should not be taken concurrently with isoniazid, as they can interfere with the absorption of the medication, reducing its effectiveness.
D. Constipation is not a common side effect of isoniazid. The more frequent side effects include peripheral neuropathy and liver toxicity, making this statement incorrect.